beyond pharmaceuticals stock wallpaper beyond spring pharmaceuticals stock 3rd Party Ad. Price target decreased to US610. Bysi Beyondspring Shares Crater After Fda Rejects Plinabulin App… Friday, October 21, 2022 Edit